Acupuncture and Chemotherapy-induced nausea and vomiting (CINV)

Deep Dive

From a Western clinical perspective, chemotherapy triggers emesis through peripheral and central pathways. Enterochromaffin cells release seroto... From a Western clinical perspective, chemotherapy triggers emesis through peripheral and central pathways. Enterochromaffin cells release serotonin that activates 5‑HT3 receptors on vagal afferents, signaling to the nucleus tractus solitarius and area postrema; substance P acting on NK1 receptors, dopaminergic inputs, and higher cortical conditioning also play roles. Antiemetic regimens target these nodes, yet nausea and occasional vomiting persist for many patients. Acupuncture and acupressure have been studied as adjuncts, with a focus on stimulating P6 (Neiguan) and related points. Randomized trials and meta-analyses report that P6 stimulation—via needles, electrical current, or noninvasive devices—can reduce acute vomiting risk and the need for rescue antiemetics when added to standard drugs. Effects on nausea intensity and delayed or anticipatory phases are more variable. Importantly, comparisons between true and sham acupuncture often yield small differences. This likely reflects the difficulty of blinding in acupuncture research and the fact that many sham techniques provide some sensory or point-adjacent stimulation, which may itself modulate vagal and central pathways. Expectancy and contextual effects further influence symptom reports. Even acknowledging these limitations, the totality of evidence supports offering P6-based stimulation as an adjunct for patients seeking additional nonpharmacologic options. Biologically, mechanistic studies lend plausibility: P6 stimulation appears to influence vagal tone, brainstem emetic centers, and serotonergic signaling, and it may engage endogenous opioids. Because these mechanisms are partially distinct from those of 5‑HT3/NK1 antagonists and corticosteroids, additive benefit is reasonable and pharmacokinetic interactions are not expected. Safety in oncology focuses on avoiding infection and bleeding: single-use sterile needles, deferring or modifying needling during profound neutropenia or thrombocytopenia, avoiding needle placement near ports/lines and recent surgical or radiation fields, and skipping electroacupuncture in patients with implanted electrical devices. Practical integration typically involves treatment shortly before or on the day of chemotherapy, with follow-up or self-administered acupressure for several days afterward. Realistic expectations are a small-to-moderate average benefit with substantial individual variability, best tracked by simple symptom diaries and rescue medication logs while maintaining adherence to guideline-based antiemetics.